United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
1996_register
executive
2010-09-24
article
Schedules of Controlled Substances: Proposed Placement of Remifentanil Into Schedule II
Proposed Rules
D09002ee1be02e4d0
D09002ee1be02e559
United States
Department of Justice
originator
org
United States Government Agency or Subagency
United States
Drug Enforcement Administration
originator
org
United States Government Agency or Subagency
This proposed rule is issued by the deputy Administrator of the Drug Enforcement Administration (DEA) to place the narcotic drug, remifentanil and salts thereof, into Schedule II of the Controlled Substances Act (CSA). The Deputy Administrator has received a recommendation from the Assistant Secretary for Health of the Department of Health and Human Services (DHHS) that remifentanil, and salts thereof, be added to Schedule II. This rule, if finalized, would require that the manufacture, distribution, dispensing, security, registration, record keeping, inventory, exportation and importation of remifentanil, and salts thereof, be subject to the CSA regulatory control mechanisms and criminal sanctions applicable to Schedule II narcotic substances.
61 FR 48655
https://www.govinfo.gov/app/details/FR-1996-09-16/96-23557
96-23557
fr16se96-28
4410-09-M
DEA-152P
https://www.govinfo.gov/app/details/FR-1996-09-16/96-23557
https://www.govinfo.gov/content/pkg/FR-1996-09-16/html/96-23557.htm
https://www.govinfo.gov/content/pkg/FR-1996-09-16/pdf/96-23557.pdf
2 p.
48655
48656
61 FR 48655
Code of Federal Regulations
Title 21 Part 1308
21 CFR Part 1308
Schedules of Controlled Substances: Proposed Placement of Remifentanil Into Schedule II; Federal Register Vol. 61, Issue
PRORULE
96-23557
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
1996-10-16
DEA-152P
4410-09-M
96-23557
Notice of proposed rulemaking.
This proposed rule is issued by the deputy Administrator of the Drug Enforcement Administration (DEA) to place the narcotic drug, remifentanil and salts thereof, into Schedule II of the Controlled Substances Act (CSA). The Deputy Administrator has received a recommendation from the Assistant Secretary for Health of the Department of Health and Human Services (DHHS) that remifentanil, and salts thereof, be added to Schedule II. This rule, if finalized, would require that the manufacture, distribution, dispensing, security, registration, record keeping, inventory, exportation and importation of remifentanil, and salts thereof, be subject to the CSA regulatory control mechanisms and criminal sanctions applicable to Schedule II narcotic substances.
Comments, objections and requests for a hearing must be submitted on or before October 16, 1996.
Frank Sapienza, Acting Chief, Drug and Chemical Evaluation Section, 202-307-7183.
Federal Register
Vol. 61, no. 180
Office of the Federal Register, National Archives and Records Administration
1996-09-16
continuing
daily
deposited
born digital
225 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-1996-09-16
P0b002ee180a2898d
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr16se96
https://www.govinfo.gov/app/details/FR-1996-09-16
https://www.govinfo.gov/content/pkg/FR-1996-09-16/pdf/FR-1996-09-16.pdf
fdlp
48601
48814
DGPO
2010-09-24
2023-05-06
FR-1996-09-16
machine generated
eng
FR
FR-1996-09-16
61
180